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DEAR SIR, Hepatitis C represents a major public health problem due to its prevalence and high 
incidence of chronic disease. Until now, most reported cases of hepatitis C infection have been 
associated with intravenous drug abuse or administration of untested blood products; many fewer cases 
have resulted from sexual or vertical transmission. In 40% of patients, however, the mode of viral 
transmission remains unknown. For some of these, a nosocomial origin has been suggested [1–3], with 
particular attention paid to transmission by gastrointestinal endoscopy [4–6]. However, the number of 
reported cases of patient-to-patient transmission associated with invasive medical procedures (IMPs) 
remains very low. 
Between 1994 and 1997, we diagnosed 20 cases of acute, icteric hepatitis C, nine of which were 
attributable to invasive medical procedures. Although sequencing or genotyping were not carried out to 
confirm the identity of the viral strains involved, we were convinced of a causal relationship by a series 
of chronological, clinical, biological and viral events (Table 1). Furthermore, these nine cases 
were subsequently traced to errors in disinfection procedures. 
Prior to IMP, all nine patients had normal levels of transaminases; none of them had ever received 
blood products or used intravenous drugs, and all sexual partners were seronegative for the C virus. 
The IMPs, which involved various medical specialities, were performed in several medical centres. 
Icteric hepatitis appeared an average of 50 days (range 32–91) after the procedure. The presence of 
viral HCV-RNA was confirmed by polymerase chain reaction (PCR) in all cases. Four of the nine 
patients were seropositive at the time of icterus, whilst five others converted to seropositivity within 4.5 
months. 
Clinical evolution to chronic hepatitis was observed in four patients (patients 1, 3, 5 and 8), whilst in 
three patients (patients 2, 7 and 9), the hepatitis spontaneously resolved (with sustained biochemical 
resolution and undetectable serum hepatitis C virus RNA 32, 12 and 24 months, respectively, after the 
end of icterus). Two patients (patients 4 and 6), who were treated early after the resolution of icterus 
with interferon α-2b (5 million units day-1 for 2 months), had apparent cure (normal transaminase 
levels and negative PCR 6 months after the end of treatment). 
 
 




















1 64 F Cystoscopy, IVPa 52 1244 Negative 3.5 months 
2 40 M Extracorporeal lithotripsy 45 1365 Positive  
3 20 M Cystoscopy + biopsies 58 294 Positive  
4b 47 M IVP 91 483 Positive  
5b 37 F Cystoscopy + IVP 49 1050 Negative 4.5 months 
6 21 F Cystoscopy + IVP 34 1399 Negative 2 months 
7 41 F Cholecystectomy (coelioscopy) 41 764 Negative 4.5 months 
8 44 F Colonoscopy + biopsies 32 478 Negative 3 months 
9 64 F Gastroscopy + biopsies 49 653 Positive  
aIntravenous pyelography. bPatients 4 and 5 were contaminated on the same day in the same medical 
centre. 
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These observations strongly suggest that patient-to-patient transmission of the hepatitis C virus via 
invasive medical procedures could be significantly more frequent than previously thought. This is all 
the more likely given that only icteric cases, which account for only 5–10% of hepatitis C infection, 
come to medical attention. We therefore suspect that many more patients might have been 
contaminated and developed clinically unapparent hepatitis during this 4-year period in our 
geographical area. 
The risk of hepatitis C virus transmission associated with gastrointestinal endoscopic procedures, 
especially when a biopsy is performed [7], has been raised in the literature; this has led to publication 
of strict recommendations concerning disinfection procedures [8, 9]. It is worth noting that in our series 
the IMPs predominantly involved specialities other than gastroenterology, especially urology. For this 
reason, it would appear urgent to define, and widely propagate, guidelines for disinfection of medical 
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